Ascendis Pharma's Yorvipath and Skytrofa drove Q3 revenues to €213.6 million, nearly quadrupling year-over-year. Read why ...

CCL Industries is analyzed through its business segments, acquisition strategy, and competitive positioning. Read why CCLLF ...

For many families affected by the opioid crisis, OxyContin maker Purdue Pharma's bankruptcy has been a long and difficult process.

Algia Pharma’s novel multimodal pain regimen, AlgiaPak®, designed to deliver opioid-level pain relief without addiction riskPositive feedback from FDA suggests an indication from perioperative pain to ...

Nine drug manufacturers will offer their drugs to Medicaid recipients at most-favored-nation discounts in exchange for tariff ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

CNW/ - DeFloria Inc., a botanical drug development Company recognizes the Presidential Executive Order to reclassify cannabis ...

QPR Software Plc has signed a three-year extension agreement with one of the world’s leading pharmaceutical companies. The agreement covers licenses for the QPR ProcessAnalyzer process mining software ...

For these women, menopause wasn’t to be experienced quietly. With the help of their doctors and the right treatment option, ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...